Categoria
NU-Verap
Nombres de marca,
NU-Verap
Analogos
NU-Verap
Marca los nombres de mezcla
Tarka (trandolapril + verapamil hydrochloride)
NU-Verap
Formula quimica
C27H38N2O4
NU-Verap
RX enlace
http://www.rxlist.com/cgi/generic/verapsr.htm
NU-Verap
FDA hoja
NU-Verap
MSDS (hoja de seguridad de materiales)
NU-Verap
Sintesis de referencia
Dengel, EE.UU. Pat. 3,261,859 (1966)
NU-Verap
Peso molecular
454.602 g/mol
NU-Verap
Punto de fusion
< 25 oC
NU-Verap
H2O Solubilidad
4,47 mg / L
NU-Verap
Estado
Liquid
NU-Verap
LogP
5.931
NU-Verap
Formas de dosificacion
Cápsulas (liberación sostenida), líquido, solución, Tablet, Tablet (de liberación prolongada)
NU-Verap
Indicacion
Para el tratamiento de la hipertensión y la angina de pecho.
NU-Verap
Farmacologia
Verapamilo, un agente antiarrítmico de clase IV, se utiliza como calcio, bloqueadores de los canales (CCB) agente para el tratamiento de la angina, la hipertensión y las taquiarritmias supraventriculares.
NU-Verap
Absorcion
90%
NU-Verap
Toxicidad
LD50 = 8 mg / kg (iv en ratones)
NU-Verap
Informacion de Pacientes
Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some
chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug
interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly
advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate
to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more
fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses
may need some adjustment, make sure to have your condition monitored regularly.
NU-Verap
Organismos afectados
Humanos y otros mamíferos